Risedronic Acid | USP | Pharmacopoeia | Reference Standards | PharmaCompass.com

Please Wait

Applying Filters...

Risedronic Acid

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

41 API Suppliers, 17 USDMF, 8 CEP/COS, 6 JDMF, 11 EU WC, 26 KDMF, 9 NDC API, 26 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

7 Intermediates Suppliers

7 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

230 FDF Dossiers, 38 FDA Orange Book, 143 Europe, 4 Canada, 23 Australia, 5 South Africa, 17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 150MG, TABLET;ORAL - 30MG, TABLET;ORAL - 35MG, TABLET;ORAL - 5MG, TABLET;ORAL - 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - 35MG

DIGITAL CONTENT

10 NEWS #PharmaBuzz

10 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 121 Finished Drug Prices, 1 Annual Reports

MARKET PLACE

5 APIs

5 APIs

PATENTS & EXCLUSIVITIES

3 US Patents, 15 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 3 JP, 4 Others

$ Xls

Filters

Filters

FILTER :

filter Catalog Number Reset all filters

1 All

01 11604610

filter Description Reset all filters

filter CAS Number Reset all filters

Product Main Page

01

USP

Antibody Engineering

Not Confirmed

Contact us
to update this info